Newton, Massachusetts, United States The leading representative office of defined VC is situated in the Newton. The company was established in North America in United States.
The fund was created by Kevin Connors. The overall number of key employees were 2.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Spray Venture Partners, startups are often financed by New Leaf Venture Partners, Sprout Group, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are New Leaf Venture Partners, New Enterprise Associates, EDF Ventures. In the next rounds fund is usually obtained by New Leaf Venture Partners, New Enterprise Associates, DeNovo Ventures.
Among the most popular portfolio startups of the fund, we may highlight Direct Flow Medical, Conventus Orthopaedics, Tryton Medical. We can highlight the next thriving fund investment areas, such as Hospital, Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
When the investment is from Spray Venture Partners the average startup value is 10-50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2014. The important activity for fund was in 2007. Comparing to the other companies, this Spray Venture Partners performs on 11 percentage points less the average number of lead investments. Considering the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Alter Global | California, San Francisco, United States |
| Avrhm Capital | - |
| Barrick Gold Corporation | Canada, Ontario, Toronto |
| Black Granite Capital | New York, New York, United States |
| Caesarea Medical Electronics | Caesarea, Hefa, Israel |
| Eesti Arengufond | Estonia, Harjumaa, Tallinn |
| Emerson Climate Technologies | Ohio, Sidney, United States |
| Endeavour Investment Partners | Hingham, Massachusetts, United States |
| Impact Venture Capital | Burlingame, California, United States |
| Jianyin International Capital Management | - |
| Kaskus | - |
| Medtronic | Minneapolis, Minnesota, United States |
| Pamplona Capital Management | England, London, United Kingdom |
| Shenzhen Huanuo Innovation | China, Guangdong, Shenzhen |
| Socially Financed | - |
| South West Angel and Investor Network (Swain) | Bristol, England, United Kingdom |
| Sygnum | Switzerland, Zürich, Zurich |
| Tao Tsuot | HaMerkaz, Israel, Petah Tiqva |
| W250 Venture Fund | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TearScience | $44M | 06 May 2010 | North Carolina, United States | ||
Direct Flow Medical | $40M | 05 Oct 2009 | Santa Rosa, California, United States | ||
Interlace Medical | $7M | 23 Jul 2008 | Framingham, Massachusetts, United States | ||
Tryton Medical | $14M | 10 Apr 2008 | Durham, North Carolina, United States | ||
Direct Flow Medical | $27M | 19 Oct 2007 | Santa Rosa, California, United States | ||
Leptos Biomedical | $20M | 16 Aug 2007 | California, United States | ||
Interlace Medical | $3M | 21 May 2007 | Framingham, Massachusetts, United States | ||
PneumRx | $27M | 06 Mar 2007 | Mountain View, California, United States | ||
TearScience | $15M | 17 Jan 2007 | North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TearScience | $44M | 06 May 2010 | North Carolina, United States | ||
Direct Flow Medical | $40M | 05 Oct 2009 | Santa Rosa, California, United States | ||
Interlace Medical | $7M | 23 Jul 2008 | Framingham, Massachusetts, United States | ||
Tryton Medical | $14M | 10 Apr 2008 | Durham, North Carolina, United States | ||
Direct Flow Medical | $27M | 19 Oct 2007 | Santa Rosa, California, United States | ||
Leptos Biomedical | $20M | 16 Aug 2007 | California, United States | ||
Interlace Medical | $3M | 21 May 2007 | Framingham, Massachusetts, United States | ||
PneumRx | $27M | 06 Mar 2007 | Mountain View, California, United States | ||
TearScience | $15M | 17 Jan 2007 | North Carolina, United States |
